Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1891 1
1892 1
1893 4
1894 2
1895 7
1917 1
1928 1
1951 1
1952 1
1953 1
1962 1
1965 1
1967 1
1968 1
1970 2
1980 1
1982 1
1986 2
1987 3
1989 6
1990 5
1991 1
1992 1
1993 6
1994 1
1995 2
1996 4
1998 7
1999 1
2000 4
2001 1
2002 1
2004 7
2005 4
2006 2
2007 4
2008 6
2009 1
2010 2
2011 3
2012 4
2013 3
2014 2
2015 2
2016 2
2017 4
2018 7
2019 7
2020 6
2021 7
2022 9
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, López-Jiménez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, Gaidano G, Lee JJ, Abhyankar S, Solano C, Perez de Oteyza J, Satlin MJ, Schwartz S, Campins M, Rocci A, Vallejo Llamas C, Lee DG, Tan SM, Johnston AM, Grigg A, Boeckh MJ, Campora L, Lopez-Fauqued M, Heineman TC, Stadtmauer EA, Sullivan KM; ZOE-HSCT Study Group Collaborators. Bastidas A, et al. JAMA. 2019 Jul 9;322(2):123-133. doi: 10.1001/jama.2019.9053. JAMA. 2019. PMID: 31287523 Free PMC article. Clinical Trial.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
Dagnew AF, Ilhan O, Lee WS, Woszczyk D, Kwak JY, Bowcock S, Sohn SK, Rodriguez Macías G, Chiou TJ, Quiel D, Aoun M, Navarro Matilla MB, de la Serna J, Milliken S, Murphy J, McNeil SA, Salaun B, Di Paolo E, Campora L, López-Fauqued M, El Idrissi M, Schuind A, Heineman TC, Van den Steen P, Oostvogels L; Zoster-039 study group. Dagnew AF, et al. Among authors: milliken s. Lancet Infect Dis. 2019 Sep;19(9):988-1000. doi: 10.1016/S1473-3099(19)30163-X. Epub 2019 Aug 6. Lancet Infect Dis. 2019. PMID: 31399377 Clinical Trial.
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.
Potential intravenous immunoglobulin-induced optic disc edema.
Britton AK, Vaze A, Milliken S, Fraser CL. Britton AK, et al. Among authors: milliken s. Am J Ophthalmol Case Rep. 2022 Jun 16;27:101617. doi: 10.1016/j.ajoc.2022.101617. eCollection 2022 Sep. Am J Ophthalmol Case Rep. 2022. PMID: 35789798 Free PMC article.
The prophylaxis of fungal infections.
Powles RL, Milliken S. Powles RL, et al. Among authors: milliken s. J Antimicrob Chemother. 1991 Jul;28 Suppl A:97-103. doi: 10.1093/jac/28.suppl_a.97. J Antimicrob Chemother. 1991. PMID: 1938710 Review.
Reducing the radicality of surgery for vulvar cancer: are smaller margins safer?
Milliken S, May J, Sanderson PA, Congiu MA, D'Oria O, Golia D'Augè T, Caruso G, DI Donato V, Benedetti Panici P, Giannini A. Milliken S, et al. Minerva Obstet Gynecol. 2021 Apr;73(2):160-165. doi: 10.23736/S2724-606X.20.04743-7. Epub 2020 Dec 11. Minerva Obstet Gynecol. 2021. PMID: 33306289 Review.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Di Ciaccio PR, Polizzotto MN, Cwynarski K, Gerrie AS, Burton C, Bower M, Kuruvilla J, Montoto S, McKay P, Fox CP, Milliken S, Jiamsakul A, Osborne W, Collins GP, Manos K, Linton KM, Iyengar S, Kassam S, Limei MP, Kliman D, Wong Doo N, Watson AM, Fedele P, Yannakou CK, Hunt S, Ku M, Sehn LH, Smith A, Renshaw H, Maxwell A, Liu Q, Dhairyawan R, Ferguson G, Pickard K, Painter D, Thakrar N, Song KW, Hamad N. Di Ciaccio PR, et al. Among authors: milliken s. Blood. 2024 Jan 11;143(2):152-165. doi: 10.1182/blood.2023021348. Blood. 2024. PMID: 37832030 Free article.
Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility.
Mills GS, Chadwick V, Tang C, Perram J, Anderson MA, Anazodo A, Kidson-Gerber G, Shand A, Lavee O, Withers B, Milliken S, Di Ciaccio PR, Hamad N. Mills GS, et al. Among authors: milliken s. Lancet Haematol. 2023 Jun;10(6):e458-e467. doi: 10.1016/S2352-3026(23)00059-5. Lancet Haematol. 2023. PMID: 37263722 Review.
Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis.
Brennan X, Withers B, Jabbour A, Milliken S, Kotlyar E, Fay K, Ma D, Muthiah K, Hamad N, Dodds A, Bart N, Keogh A, Hayward C, Macdonald P, Moore J. Brennan X, et al. Among authors: milliken s. Intern Med J. 2022 Oct;52(10):1826-1830. doi: 10.1111/imj.15926. Intern Med J. 2022. PMID: 36266066 Free PMC article.
161 results